Skip to main content

Experimental Basis for Optimal Regimnes of Hyperthermic Peritoneal Chemotherapy

  • Chapter
  • First Online:
Malignant Mesothelioma and Pseudomyxoma

Abstract

Temperature exposure reliably inhibits tumor cell potential for proliferation at the temperature of not less than 43 °C only. Temperature regimens recommended for clinical treatment (40–42 °С) have no significant impact on the viability of tumor cells. Tumor growth arrest in murine models was observed only in case of preliminary warming of inoculated cells at a temperature more than 42 °С. Heating tumor cells up to 39 °С and their incubation with anticancer drugs in the mean-effective concentrations enhanced tumor cell sensitivity towards cytotoxic action of activated lymphocytes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Elias D, Raynard B, Boige V, Laplanche A, Estphan G, Malka D, Pocard M (2005) Impact of the extent and duration of cytoreductive surgery on postoperative hematological toxicity after intraperitoneal chemohyperthermia for peritoneal carcinomatosis. J Surg Oncol 90:220–225

    Article  Google Scholar 

  2. Baronzio G (2012) Hyperthermia and intracavitary chemotherapy in prevention and treatment of malignant effusions. In: Kiselevsky MV (ed) Malignant effusions: pleuritis, ascites, pericardites. Springer, Dordrecht/New York, pp 123–150

    Chapter  Google Scholar 

  3. Glehen O, Cotte E, Brigand C, Arvieux C, Sayag-Beaujard AC, FN G (2006) Therapeutic innovations in the management of peritoneal carcinomatosis from digestive origin: Cytoreductive surgery and intraperitoneal chemotherapy. Rev Med Int 27:382–391

    Article  CAS  Google Scholar 

  4. Smeenk RM, Verwaal VJ, Zoetmulder FA (2006) Toxicity and mortality of cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei – A report of 103 procedures. Eur J Surg Oncol 32:186–190

    Article  CAS  Google Scholar 

  5. Bevanda M, Orsolic N, Basic I, Vukojevic K, Benkovic V, Horvat Knezevic A, Lisicic D, Dikic D et al (2009) Prevention of peritoneal carcinomatosis in mice with combination hyperthermal intraperitoneal chemotherapy and IL-2. Int J Hyperth 25(2):132–140

    Article  CAS  Google Scholar 

  6. Fuggetta MP, Alvino E, Tricarico M, D’Atri S, Pepponi R, Prete SP, Bonmassar E (2000) Adjuvant chemotherapy in gastric cancer: 5-year results of a randomised study by the Italian Trials in Medical Oncology (ITMO) Group. Anticancer Res 20(3A):1667–1672

    CAS  PubMed  Google Scholar 

  7. Takeda T, Fukunaga K, Miyazawa K, Takahashi T, Takeda H, Takeda Y, Tanigawa K, Morisaki T, Yamamoto I, Hasegawa T (2008) Immuno-cellular therapy-basic and clinical study. Int J Hyperthermia. Gan To Kagaku Ryoho 35(12):2244–2246

    Google Scholar 

  8. Bajetta E, Buzzoni R, Mariani L, Beretta E, Bozzetti F, Bordogna G, Aitini E, Fava S, Schieppati G, Pinotti G, Visini M, Ianniello G, Di BM (2002) In vitro effect of hyperthermia on natural cell-mediated cytotoxicity. Ann Oncol 13(2):299–307

    Article  CAS  Google Scholar 

  9. Dayanc BE, Beachy SH, Ostberg JR, Repasky EA (2008) Dissecting the role of hyperthermia in natural killer cell mediated anti-tumor responses. Int J Hyperth 24(1):41–45

    Article  CAS  Google Scholar 

  10. Milani V, Noessner E (2006) Effects of thermal stress on tumor antigenicity and recognition by immune effector cells. Cancer Immunol Immunother 55(3):312–319

    Article  CAS  Google Scholar 

  11. Moseley P (2000, July 25) Stress proteins and the immune response. Immunopharmacology 48(3):299–302

    Article  CAS  Google Scholar 

  12. Anisimova NY, Kiselevskiy MV, Abdullaev AG, Malakhova NV, Sitdikova SM, Polotskiy BE, Davydov MM (2016) Effect of hyperthermia on the viability and proliferative activity of tumor cells. Russian Oncol J 21(5):250–252

    Google Scholar 

  13. Shubina IZ, Bliumenberg AG, Volkov SM, Demidov LV, Kiselevsky MV (2007) Adoptive immunotherapy of malignancies. Vestn Ross Akad Med Nauk 11:9–15

    Google Scholar 

  14. Shubina IZ, Titov KS, Mikhailova IN, Kiselevsky MV (2014) Looking into the future of immunotherapy or how to find Cinderella? Int J Cancer Prev 6(3–4):413–424

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Anisimova, N.Y., Zhubina, I.Z., Donenko, F.V., Dolzhikova, J.I., Kshnaykina, A.V., Kiselevskiy, M.V. (2019). Experimental Basis for Optimal Regimnes of Hyperthermic Peritoneal Chemotherapy. In: Kiselevskiy, M., Abdulaev, A., Davydov, M. (eds) Malignant Mesothelioma and Pseudomyxoma . Springer, Cham. https://doi.org/10.1007/978-3-319-99510-6_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-99510-6_5

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-99509-0

  • Online ISBN: 978-3-319-99510-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics